FLXN

Flexion Therapeutics Inc.

Price

$24.56

return (12m)

4.64%

p/e

-12.25

p/bv

-14.98

DIVIDEND YIELD

9.42%

FLXN price

Flexion Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment FLXN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-1.52%

3 months

-0.58%

1 year

4.64%

2 years

0.00%

5 years

325.46%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals FLXN

Valuation

P/E

-12.25

Sector -3.53

Industry -3.53

P/BV

-14.98

Sector 2.06

Industry 2.06

P/Revenue (PSR)

12.29

Sector 2.02

Industry 2.02

EV/EBITDA

-57.00

Sector -222.67

Industry -222.67

EV/EBIT

-54.73

Sector -47.57

Industry -47.57

P/EBITDA

-16.30

Sector -21.45

Industry -21.45

P/EBIT

-15.54

Sector -28.49

Industry -28.49

P/Total Assets

5.66

Sector 1.20

Industry 1.20

P/Net Current Assets

-11.47

Sector -10.32

Industry -10.32

P/Working Capital

8.29

Sector -169.93

Industry -169.93

EPS

-2.01

Sector -1.79

Industry -1.79

BVPS

-1.65

Sector 2.05

Industry 2.05

Efficiency

Gross Margin

78.93%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-110.41%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-115.00%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-78.16%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.10

Sector 0.02

Industry 0.02

Profitability

ROE

122.27%

Sector -56.67%

Industry -56.67%

ROA

-46.22%

Sector -59.91%

Industry -59.91%

ROIC

-180.79%

Sector -2,349.21%

Industry -2,349.21%

Dividends

Dividend yield

9.42%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.38

Sector 2.88

Industry 2.88

Net Debt / EBITDA

-4.61

Sector -14,043,974.86

Industry -14,043,974.86

Net Debt / EBIT

-4.42

Sector -8.02

Industry -8.02

Net Debt / Equity

-1.32

Sector -32,936.86

Industry -32,936.86

Gross Debt / Equity

-3.04

Sector -0.84

Industry -0.84

Equity/Assets

-0.38

Sector 0.46

Industry 0.46

Liabilities/Assets

1.38

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

6.27%

Sector -

Industry -

5Y Earnings CAGR

4.44%

Sector -

Industry -

Fundamentals FLXN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
FLXN Flexion Therapeutics Inc.	$24.56	4.64%	9.42%	-12.25	-14.98	122.27%	-100.00%
JNJ Johnson & Johnson	$264.37	51.83%	1.98%	30.47	7.54	24.76%	21.48%
PFE Pfizer Inc.	$27.50	23.30%	6.24%	35.93	1.84	5.11%	6.86%
ABBV AbbVie Inc.	$263.69	24.63%	2.65%	72.22	-76.87	-106.44%	9.81%
NVO Novo Nordisk A/S	$42.73	-19.34%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$143.48	80.02%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$163.21	6.36%	2.03%	19.00	4.89	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.76	44.55%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$73.56	-49.41%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$378.12	40.58%	2.25%	26.93	20.14	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$779.26	36.63%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$106.73	38.79%	0.00%	30.46	87.77	288.13%	24.86%
MCK McKesson Corporation	$896.58	26.67%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$514.66	30.45%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$232.56	54.70%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$994.76	31.52%	0.00%	2.61	3.00	114.60%	44.55%
HRMY Harmony Biosciences Holdings Inc.	$41.09	26.86%	0.00%	13.26	2.41	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

FLXN Historical Dividends

current DY: 9.42%

5-year average DY: 9.42%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	08/25/2026	08/27/2026	0.17500000
Dividends	07/24/2026	07/28/2026	0.20000000
Dividends	06/26/2026	06/30/2026	0.22380000
Dividends	05/27/2026	05/29/2026	0.19000000
Dividends	04/24/2026	04/28/2026	0.68300000
Dividends	02/26/2026	03/02/2026	0.11490000
Dividends	12/23/2025	12/26/2025	0.73900000
Dividends	08/21/2025	08/25/2025	0.14580000

ABOUT Flexion Therapeutics

Flexion Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

19 years

Founded: 2007

2014

Time since IPO - 12 years

257

Employees

Flexion Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.23 billion, with shareholders equity totaling $-82.38 million.

The company employs approximately 257 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Flexion Therapeutics Inc. reported $100.41 million in revenue, generating net income of $-100.73 million.

Key financial metrics include a P/E ratio of -12.25, a price-to-book (P/B) ratio of -14.98, and a trailing twelve-month dividend yield of 9.42%.

The company trades under the ticker FLXN.

Market cap

$1.23 billion

Net worth

$-82.38 million

$-82,380,000.00

Assets

$217.93 million

$217,930,000.00

Total Shares Outstanding

50.00 million

50,000,000

Average Daily Trading Volume

$31.39 Thousand

$31,387.68

Sector

Health Care

Industry

Biotechnology

FLXN

FLXN revenue and profits

Financial Results FLXN

DRAG THE FRAME TO SEE MORE DATA

FLXN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$896.58 28,21% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$232.56 56,73% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$264.37 52,40% (12M)

P/E

30.47

1.98%

ROE

24.76%

P/BV

7.54

ABBV - AbbVie

$263.69 25,04% (12M)

P/E

72.22

2.65%

ROE

-106.44%

P/BV

-76.87

MRK - Merck & Co.

$143.48 83,99% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$163.21 7,03% (12M)

P/E

19.00

2.03%

ROE

25.77%

P/BV

4.89

PFE - Pfizer

$27.50 22,78% (12M)

P/E

35.93

6.24%

ROE

5.11%

P/BV

1.84

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$896.58 28,21% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$232.56 56,73% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$264.37 52,40% (12 M)

P/L

30.47

1.98%

ROE

24.76%

P/VP

7.54

ABBV - AbbVie

$263.69 25,04% (12 M)

P/L

72.22

2.65%

ROE

-106.44%

P/VP

-76.87

MRK - Merck & Co.

$143.48 83,99% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$163.21 7,03% (12 M)

P/L

19.00

2.03%

ROE

25.77%

P/VP

4.89

PFE - Pfizer

$27.50 22,78% (12 M)

P/L

35.93

6.24%

ROE

5.11%

P/VP

1.84

Frequently Asked Questions

What is the price of Flexion Therapeutics (FLXN) today?

A cotação de Flexion Therapeutics (FLXN) hoje está em US$ 24.56, com uma variação de 4.64% em relação ao último ano. A cotação de Flexion Therapeutics (FLXN) iniciou o ano negociando na casa dos US$ 25.37 e hoje está em US$ 24.56. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Flexion Therapeutics (FLXN) e dados de ações do Ibovespa e mercados internacionais.

Quando Flexion Therapeutics (FLXN) paga dividendos?

Flexion Therapeutics (FLXN) distribuiu dividendos no último ano,in the months of March, April, May, June, July and August totalizando R$ 1.59. O Dividend Yield referente aos 12 últimos meses é de 9.42%.

Is Flexion Therapeutics (FLXN) a good investment?

Atualmente, Flexion Therapeutics (FLXN) está cotada a US$ 24.56, com um P/L de -12.25, representando um desvio de 0% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 4.64 em sua cotação e distribuiu US$ 1.59 em dividendos, resultando em um Dividend Yield de 9.42%. O retorno total do acionista foi de 4.64%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Flexion Therapeutics (FLXN) stock?

Investir em ações de Flexion Therapeutics (FLXN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Flexion Therapeutics (FLXN) yield today?

A rentabilidade de Flexion Therapeutics (FLXN) foi de -1.52% no último mês, 4.64% no último ano e 325.46% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 2.33 em dividendos, um Dividend Yield de 9.42%.

Se você quisesse comprar 100 ações de Flexion Therapeutics (FLXN) hoje, o investimento total seria de US$ 2,455.99, com base na cotação atual de US$ 24.56.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 2,569.95
Em 5 anos: US$ 10,449.26
Em 10 anos: US$ 2,455.99

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

FLXN

Flexion Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment FLXN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING FLXN WITH OTHER STOCK

current DY: 9.42%

5-year average DY: 9.42%

type

Ex - Dividend Date

payment date

value

ABOUT Flexion Therapeutics

Flexion Therapeutics Inc.

United States

19 years

2014

257

Financial Results FLXN

FLXN cash flow

Asset, Revenue and Profit Growth - FLXN

FLXN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions